These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 20559286)
41. [The effect of body position on the secretion and metabolism of aldosterone in man (author's transl)]. Bultasová H; Hrnová Z; Veselková A; Pinsker P Cas Lek Cesk; 1977 Jan; 116(2):17-22. PubMed ID: 837387 [No Abstract] [Full Text] [Related]
42. The adrenal cortex in internal medicine. II. Cope CL Br Med J; 1966 Oct; 2(5519):914-21. PubMed ID: 5331425 [No Abstract] [Full Text] [Related]
43. The low density lipoprotein receptor: structure, function and pharmacological modulation. Catapano AL Pharmacol Ther; 1989; 43(2):187-219. PubMed ID: 2675133 [No Abstract] [Full Text] [Related]
44. Some studies on the biosynthesis of aldosterone and other adrenal steroids. AYRES PJ; EICHHORN J; HECHTER O; SABA N; TAIT JF; TAIT SA Acta Endocrinol (Copenh); 1960 Jan; 33():27-58. PubMed ID: 13795368 [No Abstract] [Full Text] [Related]
45. Steroids of adrenal cortical type including aldosterone. PRUNTY FT Practitioner; 1955 Jul; 175(1045):89-95. PubMed ID: 13245594 [No Abstract] [Full Text] [Related]
46. Chemical and clinical endocrinology of aldosterone. BERNSTEIN RE S Afr Med J; 1959 May; 33(22):452-9. PubMed ID: 13668691 [No Abstract] [Full Text] [Related]
47. Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects. Rathi H; Kumar R; Goyal B; Kant R; Mirza AA; Rana S; Naithani M J Lab Physicians; 2022 Dec; 14(4):420-426. PubMed ID: 36531545 [No Abstract] [Full Text] [Related]
48. The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality. Cho KH Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409326 [TBL] [Abstract][Full Text] [Related]
49. High cortisol levels are associated with oxidative stress and mortality in maintenance hemodialysis patients. Kim J; Yun KS; Cho A; Kim DH; Lee YK; Choi MJ; Kim SH; Kim H; Yoon JW; Park HC BMC Nephrol; 2022 Mar; 23(1):98. PubMed ID: 35260104 [TBL] [Abstract][Full Text] [Related]
51. Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways. Saha S; Graessler J; Schwarz PE; Goettsch C; Bornstein SR; Kopprasch S Mol Cell Biochem; 2012 Jul; 366(1-2):1-10. PubMed ID: 22382638 [TBL] [Abstract][Full Text] [Related]
52. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion. Kopprasch S; Pietzsch J; Ansurudeen I; Graessler J; Krug AW; Ehrhart-Bornstein M; Bornstein SR J Endocrinol; 2009 Jan; 200(1):45-52. PubMed ID: 18835979 [TBL] [Abstract][Full Text] [Related]
53. Angiotensin II and the adrenal. Giacchetti G; Opocher G; Sarzani R; Rappelli A; Mantero F Clin Exp Pharmacol Physiol Suppl; 1996; 3():S119-24. PubMed ID: 8993850 [TBL] [Abstract][Full Text] [Related]
55. Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein. Ansurudeen I; Pietzsch J; Graessler J; Ehrhart-Bornstein M; Saha S; Bornstein SR; Kopprasch S Am J Hypertens; 2010 Oct; 23(10):1061-8. PubMed ID: 20559286 [TBL] [Abstract][Full Text] [Related]
56. Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release. Saha S; Bornstein SR; Graessler J; Kopprasch S Horm Metab Res; 2015 Oct; 47(11):855-60. PubMed ID: 25602349 [TBL] [Abstract][Full Text] [Related]
57. A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells--underlying mechanisms. Ohlsson A; Ullerås E; Oskarsson A Toxicol Lett; 2009 Dec; 191(2-3):174-80. PubMed ID: 19733639 [TBL] [Abstract][Full Text] [Related]